These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1355673)

  • 21. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
    Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
    Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ennui or not ennui, that is the question..
    Cheson BD
    Ann Oncol; 1996 Oct; 7(8):767-9. PubMed ID: 8922188
    [No Abstract]   [Full Text] [Related]  

  • 24. Purine analogues for treatment of refractory essential mixed cryoglobulinemia.
    Enzenauer RJ; Judson PH
    Mayo Clin Proc; 1997 Jan; 72(1):92-3. PubMed ID: 9005296
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 26. The mechanism of 2-chlorodeoxyadenosine-induced cell death.
    Wataya Y; Hirota Y; Hiramoto-Yoshioka A; Tanaka S; Otani T; Minowada J; Matsuda A; Ueda T
    Adv Exp Med Biol; 1989; 253B():227-34. PubMed ID: 2575349
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.
    Santana VM; Mirro J; Harwood FC; Cherrie J; Schell M; Kalwinsky D; Blakley RL
    J Clin Oncol; 1991 Mar; 9(3):416-22. PubMed ID: 1671875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of 2-chloro-2'-deoxyadenosine in human plasma.
    Liliemark J; Pettersson B; Juliusson G
    Biomed Chromatogr; 1991 Nov; 5(6):262-4. PubMed ID: 1684727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hairy-cell leukemia.
    Lill MC; Golde DW
    Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes.
    Carrera CJ; Piro LD; Saven A; Beutler E; Terai C; Carson DA
    Adv Exp Med Biol; 1991; 309A():15-8. PubMed ID: 1686349
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
    Zimmer-Molsberger B; Knauf W; Thiel E
    Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
    [No Abstract]   [Full Text] [Related]  

  • 33. Hairy cell leukaemia: review of treatment.
    Kurzrock R; Talpaz M; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-CdA in the treatment of hairy cell leukaemia.
    Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
    J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
    Carrera CJ; Terai C; Lotz M; Curd JG; Piro LD; Beutler E; Carson DA
    J Clin Invest; 1990 Nov; 86(5):1480-8. PubMed ID: 1700795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulminant hepatitis C virus infection.
    Schirmer M; Vogel W; Thaler J; Grünewald K; Umlauft F; Geisen F; Zilian U; Konwalinka G
    Lancet; 1994 Jun; 343(8910):1433. PubMed ID: 7910911
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
    Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
    Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
    Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
    Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoma, hairy-cell leukemia respond to new agents.
    Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
    [No Abstract]   [Full Text] [Related]  

  • 40. A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
    Reiter Z; Ozes ON; Tomson S; Blatt LM; Taylor MW
    Adv Exp Med Biol; 1991; 309A():69-73. PubMed ID: 1686352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.